SHORLA ONCOLOGY INC.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

SHORLA ONCOLOGY INC. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About SHORLA ONCOLOGY INC.

SHORLA ONCOLOGY INC. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by METHOTREXATE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment adults, pediatric patients, combination chemotherapy, jylamvo indicated, rheumatoid arthritis, polyarticular juvenile, acute lymphoblastic, maintenance regimen. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
METHOTREXATE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from SHORLA ONCOLOGY INC.

Brand nameGenericTypeRoute
JYLAMVO METHOTREXATE HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does SHORLA ONCOLOGY INC. make?
1 FDA drug label records name SHORLA ONCOLOGY INC. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does SHORLA ONCOLOGY INC. produce?
The most frequent active ingredients in this portfolio are METHOTREXATE.

Are SHORLA ONCOLOGY INC. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.